Mining human antibody repertoires

mAbs

Volumn 2, Issue 4, 2010, Pages 365-378

  Beerli, Roger R ^a,c   Rader, Christoph ^b  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Intercell AG   (Switzerland)

Author keywords

Antibody engineering; Antibody libraries; B cells; Display technologies; Human monoclonal antibodies; Hybridoma technology

Indexed keywords

ADALIMUMAB; ARZERRA; CANAKINUMAB; CD40 ANTIGEN; CELL SURFACE IMMUNOGLOBULIN; GOLIMUMAB; HUMAN MONOCLONAL ANTIBODY; INTERLEUKIN 4; OFATUMUMAB; PANITUMUMAB; POLYCLONAL ANTIBODY; PROTEIN BCL 6; PROTEIN BCL X; SIMPONI; SYNTHETIC DNA; TETANUS TOXOID; UNCLASSIFIED DRUG; USTEKINUMAB; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ANTIBODY ENGINEERING; ANTIBODY LIBRARY; ANTIBODY PRODUCTION; ANTIGEN BINDING; B LYMPHOCYTE; BACTERIAL INFECTION; BIOTECHNOLOGY; BONE MARROW; CELL IMMORTALIZATION; CELL SELECTION; CHRONIC LYMPHATIC LEUKEMIA; CINCA SYNDROME; COLORECTAL CANCER; COMBINATORIAL CHEMISTRY; CROHN DISEASE; DRUG APPROVAL; DRUG CHOICE; DRUG DESIGN; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; HEAVY CHAIN; HUMAN; HYBRIDOMA; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOTHERAPY; JUVENILE RHEUMATOID ARTHRITIS; LIGHT CHAIN; LYMPHOCYTE ACTIVATION; MAMMAL CELL; METASTASIS; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHAGE DISPLAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SACCHAROMYCES CEREVISIAE; TRANSGENIC MOUSE; VACCINATION; VIRUS INFECTION; YEAST; ANIMAL; ANTIGEN MEDIATED CLONAL SELECTION; BIOSYNTHESIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PEPTIDE LIBRARY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CLONAL SELECTION, ANTIGEN-MEDIATED; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; HYBRIDOMAS; IMMUNOTHERAPY; PEPTIDE LIBRARY; YEASTS;

EID: 77957338351     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.12187     Document Type: Review

References (179)

1. Hwang WY, Foote J. Immunogenicity of engineered antibodies. Methods 2005; 36:3-10.
2. Weiner LM. Fully human therapeutic monoclonal antibodies. J Immunother 2006; 29:1-9.
3. Swann PG, Tolnay M, Muthukkumar S, Shapiro MA, Rellahan BL, Clouse KA. Considerations for the development of therapeutic monoclonal antibodies. Curr Opin Immunol 2008; 20:493-9.
4. Weiner LM, Dhodapkar MV, Ferrone S. Monoclonal antibodies for cancer immunotherapy. Lancet 2009; 373:1033-40.
5. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495-7.
6. Steinitz M. Three decades of human monoclonal antibodies: past, present and future developments. Hum Antibodies 2009; 18:1-10.
7. Lonberg N. Fully human antibodies from transgenic mouse and phage display platforms. Curr Opin Immunol 2008; 20:450-9.
8. Hoogenboom HR. Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005; 23:1105-16.
9. Reichert JM. Monoclonal antibodies in the clinic. Nat Biotechnol 2001; 19:819-22.
10. Dimitrov DS, Marks JD. Therapeutic antibodies: current state and future trends - is a paradigm change coming soon? Methods Mol Biol 2009; 525:1-27.
11. Reichert JM. Antibodies to watch in 2010. MAbs 2010; 2:84-100.
12. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 2008; 112:1570-80.
13. Xu L, Yee H, Chan C, Kashyap AK, Horowitz L, Horowitz M, et al. Combinatorial surrobody libraries. Proc Natl Acad Sci USA 2008; 105:10756-61.
14. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005; 23:487-513.
15. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005; 23:367-86.
16. Lanzavecchia A, Sallusto F. Human B cell memory. Curr Opin Immunol 2009; 21:298-304.
17. Vollmers HP, Brandlein S. Natural IgM antibodies: the orphaned molecules in immune surveillance. Adv Drug Deliv Rev 2006; 58:755-65. (Pubitemid 44247229)
18. Lane HC, Shelhamer JH, Mostowski HS, Fauci AS. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual. J Exp Med 1982; 155:333-8.
19. Nowinski R, Berglund C, Lane J, Lostrom M, Bernstein I, Young W, et al. Human monoclonal antibody against Forssman antigen. Science 1980; 210:537-9.
20. Schlom J, Wunderlich D, Teramoto YA. Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc Natl Acad Sci USA 1980; 77:6841-5. (Pubitemid 11219041)
21. Croce CM, Shander M, Martinis J, Cicurel L, D'Ancona GG, Koprowski H. Preferential retention of human chromosome 14 in mouse X human B cell hybrids. Eur J Immunol 1980; 10:486-8. (Pubitemid 10037004)
22. Yoshinari K, Arai K, Kimura H, Matsumoto K, Yamaguchi Y. Long-term production of human monoclonal antibodies by human-mouse heterohybridomas. J Immunol Methods 1995; 186:17-25.
23. Chiorazzi N, Wasserman RL, Kunkel HG. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas. J Exp Med 1982; 156:930-5. (Pubitemid 12027000)
24. Cote RJ, Morrissey DM, Houghton AN, Beattie EJ Jr, Oettgen HF, Old LJ. Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci USA 1983; 80:2026-30.
25. Croce CM, Linnenbach A, Hall W, Steplewski Z, Koprowski H. Production of human hybridomas secreting antibodies to measles virus. Nature 1980; 288:488-9. (Pubitemid 11163962)
26. Houghton AN, Brooks H, Cote RJ, Taormina MC, Oettgen HF, Old LJ. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J Exp Med 1983; 158:53-65. (Pubitemid 13073511)
27. Larrick JW, Truitt KE, Raubitschek AA, Senyk G, Wang JC. Characterization of human hybridomas secreting antibody to tetanus toxoid. Proc Natl Acad Sci USA 1983; 80:6376-80.
28. Olsson L, Kaplan HS. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 1980; 77:5429-31. (Pubitemid 11195580)
29. Cooper MD, Kirkpatrick R. Production of stable heterohybridomas producing human monoclonal antibodies. Methods Mol Biol 1995; 45:29-39.
30. Ostberg L, Pursch E. Human X (mouse X human) hybridomas stably producing human antibodies. Hybridoma 1983; 2:361-7.
31. Posner MR, Elboim H, Santos D. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Hybridoma 1987; 6:611-25.
32. Teng NN, Lam KS, Calvo Riera F, Kaplan HS. Construction and testing of mouse - human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci USA 1983; 80:7308-12.
33. Karpas A, Dremucheva A, Czepulkowski BH. A human myeloma cell line suitable for the generation of human monoclonal antibodies. Proc Natl Acad Sci USA 2001; 98:1799-804.
34. Dessain SK, Adekar SP, Stevens JB, Carpenter KA, Skorski ML, Barnoski BL, et al. High efficiency creation of human monoclonal antibody-producing hybridomas. J Immunol Methods 2004; 291:109-22.
35. Adekar SP, Jones RM, Elias MD, Al-Saleem FH, Root MJ, Simpson LL, et al. Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins. J Immunol Methods 2008; 333:156-66.
36. Duchosal MA, Eming SA, Fischer P, Leturcq D, Barbas CF 3rd, McConahey PJ, et al. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 1992; 355:258-62.
37. Carlsson R, Martensson C, Kalliomaki S, Ohlin M, Borrebaeck CA. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. J Immunol 1992; 148:1065-71.
38. Eren R, Lubin I, Terkieltaub D, Ben-Moshe O, Zauberman A, Uhlmann R, et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology 1998; 93:154-61.
39. Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, et al. Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J Immune Based Ther Vaccines 2004; 2:5.
40. Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 1971; 8:443-50.
41. Kozbor D, Roder JC. Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol 1981; 127:1275-80.
42. Steinitz M, Klein G, Koskimies S, Makel O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977; 269:420-2. (Pubitemid 8232781)
43. Bron D, Feinberg MB, Teng NN, Kaplan HS. Production of human monoclonal IgG antibodies against Rhesus (D) antigen. Proc Natl Acad Sci USA 1984; 81:3214-7.
44. Kozbor D, Roder JC, Chang TH, Steplewski Z, Koprowski H. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Hybridoma 1982; 1:323-8. (Pubitemid 13242075)
45. Geylis V, Kourilov V, Meiner Z, Nennesmo I, Bogdanovic N, Steinitz M. Human monoclonal antibodies against amyloid-beta from healthy adults. Neurobiol Aging 2005; 26:597-606. (Pubitemid 40228751)
46. Lang AB, Furer E, Senyk G, Larrick JW, Cryz SJ Jr. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Hum Antibodies Hybridomas 1990; 1:96-103.
47. Ohlin M, Broliden PA, Danielsson L, Wahren B, Rosen J, Jondal M, et al. Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping. Immunology 1989; 68:325-31.
48. Yu X, McGraw PA, House FS, Crowe JE Jr. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods 2008; 336:142-51.
49. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008; 455:532-6.
50. Shammah S, Mantovani TL, Dalla-Favera R, Casali P. Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene. J Immunol Methods 1993; 160:19-25. (Pubitemid 23085111)
51. Simmons CP, Bernasconi NL, Suguitan AL, Mills K, Ward JM, Chau NV, et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 2007; 4:178.
52. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004; 10:871-5.
53. Wen L, Hanvanich M, Werner-Favre C, Brouwers N, Perrin LH, Zubler RH. Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies. Eur J Immunol 1987; 17:887-92. (Pubitemid 17101883)
54. Zubler RH, Erard F, Lees RK, Van Laer M, Mingari C, Moretta L, et al. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol 1985; 134:3662-8. (Pubitemid 15034370)
55. Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin- 4 and antibody to CD40. Science 1991; 251:70-2. (Pubitemid 21916853)
56. Rousset F, Garcia E, Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991; 173:705-10.
57. Lagerkvist AC, Furebring C, Borrebaeck CA. Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning. Biotechniques 1995; 18:862-9.
58. Weitkamp JH, Kallewaard N, Kusuhara K, Feigelstock D, Feng N, Greenberg HB, et al. Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J Immunol Methods 2003; 275:223-37. (Pubitemid 36351557)
59. Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009; 326:285-9.
60. Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, Lukens MV, et al. Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med 2010; 16:123-8.
61. Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K, et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA 2008; 105:9727-32. (Pubitemid 352031368)
62. + memory B cells. Immunity 2007; 26:205-13.
63. Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009; 458:636-40.
64. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667-71.
65. Meijer PJ, Andersen PS, Haahr Hansen M, Steinaa L, Jensen A, Lantto J, et al. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol 2006; 358:764-72.
66. Poulsen TR, Meijer PJ, Jensen A, Nielsen LS, Andersen PS. Kinetic, affinity and diversity limits of human polyclonal antibody responses against tetanus toxoid. J Immunol 2007; 179:3841-50.
67. Love JC, Ronan JL, Grotenbreg GM, van der Veen AG, Ploegh HL. A microengraving method for rapid selection of single cells producing antigen-specific antibodies. Nat Biotechnol 2006; 24:703-7.
68. Jin A, Ozawa T, Tajiri K, Obata T, Kondo S, Kinoshita K, et al. A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat Med 2009; 15:1088-92.
69. Rader C. Antibody libraries in drug and target discovery. Drug Discov Today 2001; 6:36-43.
70. Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta GR, et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci USA 2009; 106:20216-21.
71. Persson MA. Twenty years of combinatorial antibody libraries, but how well do they mimic the immunoglobulin repertoire? Proc Natl Acad Sci USA 2009; 106:20137-8.
72. Huse WD, Sastry L, Iverson SA, Kang AS, Alting-Mees M, Burton DR, et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989; 246:1275-81.
73. Mullinax RL, Gross EA, Amberg JR, Hay BN, Hogrefe HH, Kubitz MM, et al. Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library. Proc Natl Acad Sci USA 1990; 87:8095-9.
74. Persson MA, Caothien RH, Burton DR. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc Natl Acad Sci USA 1991; 88:2432-6.
75. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228:1315-7.
76. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348:552-4.
77. Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. Nature 1991; 352:624-8.
78. Breitling F, Dubel S, Seehaus T, Klewinghaus I, Little M. A surface expression vector for antibody screening. Gene 1991; 104:147-53.
79. Kang AS, Barbas CF, Janda KD, Benkovic SJ, Lerner RA. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci USA 1991; 88:4363-6.
80. Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res 1991; 19:4133-7.
81. Holt LJ, Herring C, Jespers LS, Woolven BP, Tomlinson IM. Domain antibodies: proteins for therapy. Trends Biotechnol 2003; 21:484-90.
82. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005; 23:1126-36.
83. O'Connell D, Becerril B, Roy-Burman A, Daws M, Marks JD. Phage versus phagemid libraries for generation of human monoclonal antibodies. J Mol Biol 2002; 321:49-56. (Pubitemid 34948468)
84. Shi L, Wheeler JC, Sweet RW, Lu J, Luo J, Tornetta M, et al. De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins. J Mol Biol 2010.
85. Barbas CF 3rd, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 1991; 88:7978-82.
86. Burton DR, Barbas CF 3rd, Persson MA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991; 88:10134-7. (Pubitemid 21915789)
87. Zebedee SL, Barbas CF 3rd, Hom YL, Caothien RH, Graff R, DeGraw J, et al. Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci USA 1992; 89:3175-9.
88. Barbas CF 3rd, Crowe JE Jr, Cababa D, Jones TM, Zebedee SL, Murphy BR, et al. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci USA 1992; 89:10164-8.
89. Barbas CF 3rd, Collet TA, Amberg W, Roben P, Binley JM, Hoekstra D, et al. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J Mol Biol 1993; 230:812-23. (Pubitemid 23159928)
90. Williamson RA, Burioni R, Sanna PP, Partridge LJ, Barbas CF 3rd, Burton DR. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci USA 1993; 90:4141-5. (Pubitemid 23134182)
91. Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR. Human autoantibody recognition of DNA. Proc Natl Acad Sci USA 1995; 92:2529-33.
92. Roben P, Barbas SM, Sandoval L, Lecerf JM, Stollar BD, Solomon A, et al. Repertoire cloning of lupus anti-DNA autoantibodies. J Clin Invest 1996; 98:2827-37. (Pubitemid 26427412)
93. Siegel DL. Translational applications of antibody phage display. Immunol Res 2008; 42:118-31.
94. Hansen MH, Nielsen H, Ditzel HJ. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proc Natl Acad Sci USA 2001; 98:12659-64.
95. Coronella JA, Spier C, Welch M, Trevor KT, Stopeck AT, Villar H, et al. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 2002; 169:1829-36.
96. Pavoni E, Monteriu G, Santapaola D, Petronzelli F, Anastasi AM, Pelliccia A, et al. Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. BMC Biotechnol 2007; 7:70.
97. Cai X, Garen A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc Natl Acad Sci USA 1995; 92:6537-41.
98. Baskar S, Suschak JM, Samija I, Srinivasan R, Childs RW, Pavletic SZ, et al. A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display. Blood 2009; 114:4494-502.
99. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222:581-97.
100. Griffiths AD, Malmqvist M, Marks JD, Bye JM, Embleton MJ, McCafferty J, et al. Human anti-self antibodies with high specificity from phage display libraries. EMBO J 1993; 12:725-34.
101. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, et al. Human antibodies with sub-nanomolar affinities isolated from a large nonimmunized phage display library. Nat Biotechnol 1996; 14:309-14.
102. Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, Schier R, et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA 1998; 95:6157-62. (Pubitemid 28248981)
103. de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem 1999; 274:18218-30. (Pubitemid 129519219)
104. Ling MM. Large antibody display libraries for isolation of high-affinity antibodies. Comb Chem High Throughput Screen 2003; 6:421-32.
105. Marks JD, Griffiths AD, Malmqvist M, Clackson TP, Bye JM, Winter G. By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology 1992; 10:779-83.
106. Kwong KY, Baskar S, Zhang H, Mackall CL, Rader C. Generation, affinity maturation and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity. J Mol Biol 2008; 384:1143-56.
107. Jespers LS, Roberts A, Mahler SM, Winter G, Hoogenboom HR. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology 1994; 12:899-903. (Pubitemid 24271128)
108. Osbourn J, Groves M, Vaughan T. From rodent reagents to human therapeutics using antibody guided selection. Methods 2005; 36:61-8. (Pubitemid 40558816)
109. Rader C, Cheresh DA, Barbas CF 3rd. A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. Proc Natl Acad Sci USA 1998; 95:8910-5. (Pubitemid 28350588)
110. Chapal N, Peraldi-Roux S, Bresson D, Pugniere M, Mani JC, Granier C, et al. Human anti-thyroid peroxidase single-chain fragment variable of Ig isolated from a combinatorial library assembled in-cell: insights into the in vivo situation. J Immunol 2000; 164:4162-9. (Pubitemid 30215074)
111. Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 1997; 15:553-7.
112. Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol 2007; 17:467-73.
113. Bowley DR, Labrijn AF, Zwick MB, Burton DR. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng Des Sel 2007; 20:81-90.
114. Feldhaus MJ, Siegel RW. Yeast display of antibody fragments: a discovery and characterization platform. J Immunol Methods 2004; 290:69-80.
115. van den Beucken T, Pieters H, Steukers M, van der Vaart M, Ladner RC, Hoogenboom HR, et al. Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries. FEBS Lett 2003; 546:288-94.
116. Walker LM, Bowley DR, Burton DR. Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library. J Mol Biol 2009; 389:365-75.
117. Feldhaus MJ, Siegel RW, Opresko LK, Coleman JR, Feldhaus JM, Yeung YA, et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol 2003; 21:163-70.
118. Blaise L, Wehnert A, Steukers MP, van den Beucken T, Hoogenboom HR, Hufton SE. Construction and diversification of yeast cell surface displayed libraries by yeast mating: application to the affinity maturation of Fab antibody fragments. Gene 2004; 342:211-8.
119. Benatuil L, Perez JM, Belk J, Hsieh CM. An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel 2010; 23:155-9.
120. Weaver-Feldhaus JM, Lou J, Coleman JR, Siegel RW, Marks JD, Feldhaus MJ. Yeast mating for combinatorial Fab library generation and surface display. FEBS Lett 2004; 564:24-34.
121. Lou J, Geren I, Garcia-Rodriguez C, Forsyth CM, Wen W, Knopp K, et al. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Eng Des Sel 2010.
122. Boder ET, Midelfort KS, Wittrup KD. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc Natl Acad Sci USA 2000; 97:10701-5.
123. Ho M, Nagata S, Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci USA 2006; 103:9637-42.
124. Smith ES, Shi S, Zauderer M. Construction of cDNA libraries in vaccinia virus. Methods Mol Biol 2004; 269:65-76.
125. Beerli RR, Bauer M, Buser RB, Gwerder M, Muntwiler S, Maurer P, et al. Isolation of human monoclonal antibodies by mammalian cell display. Proc Natl Acad Sci USA 2008; 105:14336-41.
126. Jennings GT, Bachmann MF. The coming of age of virus-like particle vaccines. Biol Chem 2008; 389:521-36.
127. Beerli RR, Bauer M, Schmitz N, Buser RB, Gwerder M, Muntwiler S, et al. Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein. Virol J 2009; 6:224.
128. Bruggemann M, Caskey HM, Teale C, Waldmann H, Williams GT, Surani MA, et al. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc Natl Acad Sci USA 1989; 86:6709-13.
129. Lonberg N. Human antibodies from transgenic animals. Nat Biotechnol 2005; 23:1117-25.
130. Green LL, Hardy MC, Maynard-Currie CE, Tsuda H, Louie DM, Mendez MJ, et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet 1994; 7:13-21.
131. Lonberg N, Taylor LD, Harding FA, Trounstine M, Higgins KM, Schramm SR, et al. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 1994; 368:856-9.
132. Alter-Wolf S, Blomberg BB, Riley RL. Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage. Mech Ageing Dev 2009; 130:401-8.
133. Xu JL, Davis MM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 2000; 13:37-45.
134. Fishwild DM, O'Donnell SL, Bengoechea T, Hudson DV, Harding F, Bernhard SL, et al. High-avidity human IgGkappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat Biotechnol 1996; 14:845-51.
135. Mendez MJ, Green LL, Corvalan JR, Jia XC, Maynard-Currie CE, Yang XD, et al. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 1997; 15:146-56.
136. Nicholson IC, Zou X, Popov AV, Cook GP, Corps EM, Humphries S, et al. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes. J Immunol 1999; 163:6898-906.
137. Tomizuka K, Shinohara T, Yoshida H, Uejima H, Ohguma A, Tanaka S, et al. Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies. Proc Natl Acad Sci USA 2000; 97:722-7.
138. Ishida I, Tomizuka K, Yoshida H, Tahara T, Takahashi N, Ohguma A, et al. Production of human monoclonal and polyclonal antibodies in TransChromo animals. Cloning Stem Cells 2002; 4:91-102.
139. Haurum JS. Recombinant polyclonal antibodies: the next generation of antibody therapeutics? Drug Discov Today 2006; 11:655-60.
140. Kuroiwa Y, Kasinathan P, Sathiyaseelan T, Jiao JA, Matsushita H, Sathiyaseelan J, et al. Nat Biotechnol 2009; 27:173-81.
141. Sidhu SS, Fellouse FA. Synthetic therapeutic antibodies. Nat Chem Biol 2006; 2:682-8.
142. Barbas CF 3rd, Bain JD, Hoekstra DM, Lerner RA. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sci USA 1992; 89:4457-61.
143. Barbas CF 3rd, Languino LR, Smith JW. High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc Natl Acad Sci USA 1993; 90:10003-7.
144. Chung J, Rader C, Popkov M, Hur YM, Kim HK, Lee YJ, et al. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation. FASEB J 2004; 18:361-3.
145. Yang WP, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF 3rd. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 1995; 254:392-403.
146. Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, et al. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol 1996; 263: 551-67.
147. H gene segments rearranged in vitro. J Mol Biol 1992; 227:381-8.
148. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994; 13:3245-60.
149. de Kruif J, Boel E, Logtenberg T. Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J Mol Biol 1995; 248:97-105.
150. Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 2005; 23:344-8.
151. Soderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Aberg AM, et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 2000; 18:852-6.
152. Low NM, Holliger PH, Winter G. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. J Mol Biol 1996; 260:359-68.
153. Cesaro-Tadic S, Lagos D, Honegger A, Rickard JH, Partridge LJ, Blackburn GM, et al. Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library. Nat Biotechnol 2003; 21:679-85.
154. Zhou Y, Drummond DC, Zou H, Hayes ME, Adams GP, Kirpotin DB, et al. Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. J Mol Biol 2007; 371:934-47.
155. Pini A, Viti F, Santucci A, Carnemolla B, Zardi L, Neri P, et al. Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem 1998; 273:21769-76.
156. Sidhu SS, Li B, Chen Y, Fellouse FA, Eigenbrot C, Fuh G. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J Mol Biol 2004; 338:299-310.
157. Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol 2004; 340:1073-93.
158. Fellouse FA, Wiesmann C, Sidhu SS. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci USA 2004; 101:12467-72.
159. Fellouse FA, Li B, Compaan DM, Peden AA, Hymowitz SG, Sidhu SS. Molecular recognition by a binary code. J Mol Biol 2005; 348:1153-62.
160. Cobaugh CW, Almagro JC, Pogson M, Iverson B, Georgiou G. Synthetic antibody libraries focused towards peptide ligands. J Mol Biol 2008; 378:622-33.
161. Schoonbroodt S, Steukers M, Viswanathan M, Frans N, Timmermans M, Wehnert A, et al. Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates. J Immunol 2008; 181:6213-21.
162. Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 2000; 296:57-86.
163. Rauchenberger R, Borges E, Thomassen-Wolf E, Rom E, Adar R, Yaniv Y, et al. Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. J Biol Chem 2003; 278:38194-205.
164. Rothe C, Urlinger S, Lohning C, Prassler J, Stark Y, Jager U, et al. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 2008; 376:1182-200.
165. Hanes J, Schaffitzel C, Knappik A, Pluckthun A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 2000; 18:1287-92.
166. Rothe A, Hosse RJ, Power BE. In vitro display technologies reveal novel biopharmaceutics. FASEB J 2006; 20:1599-610.
167. Hanes J, Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 1997; 94:4937-42.
168. He M, Taussig MJ. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res 1997; 25:5132-4.
169. Schaffitzel C, Hanes J, Jermutus L, Pluckthun A. Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. J Immunol Methods 1999; 231:119-35.
170. Thom G, Cockroft AC, Buchanan AG, Candotti CJ, Cohen ES, Lowne D, et al. Probing a protein-protein interaction by in vitro evolution. Proc Natl Acad Sci USA 2006; 103:7619-24.
171. Urban JH, Schneider RM, Compte M, Finger C, Cichutek K, Alvarez-Vallina L, et al. Selection of functional human antibodies from retroviral display libraries. Nucleic Acids Res 2005; 33:35.
172. Chen W, Zhu Z, Feng Y, Xiao X, Dimitrov DS. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain. J Mol Biol 2008; 382:779-89.
173. Xiao X, Feng Y, Vu BK, Ishima R, Dimitrov DS. A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors. Biochem Biophys Res Commun 2009; 387:387-92.
174. Wozniak-Knopp G, Bartl S, Bauer A, Mostageer M, Woisetschlager M, Antes B, et al. Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties. Protein Eng Des Sel 2010.
175. Liu CC, Mack AV, Tsao ML, Mills JH, Lee HS, Choe H, et al. Protein evolution with an expanded genetic code. Proc Natl Acad Sci USA 2008; 105:17688-93.
176. Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343-57.
177. Aarden L, Ruuls SR, Wolbink G. Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement. Curr Opin Immunol 2008; 20:431-5.
178. Mazumdar S, Greenwald D. Golimumab. MAbs 2009; 1:422-31.
179. Logtenberg T. Antibody cocktails: next-generation biopharmaceuticals with improved potency. Trends Biotechnol 2007; 25:390-4.